Parthenon LLC’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.6M Sell
112,171
-1,200
-1% -$107K 1.21% 25
2026
Q1
$8.14M Sell
113,371
-1,465
-1% -$113K 0.93% 29
2025
Q4
$9.11M Sell
114,836
-5,009
-4% -$395K 0.98% 28
2025
Q3
$9.04M Sell
119,845
-13,389
-10% -$918K 1% 28
2025
Q2
$9.19M Sell
133,234
-8,614
-6% -$565K 1.05% 27
2025
Q1
$9.61M Sell
141,848
-477
-0.3% -$28.5K 1.18% 26
2024
Q4
$6.39M Sell
142,325
-6,136
-4% -$344K 0.77% 33
2024
Q3
$9.34M Sell
148,461
-3,226
-2% -$188K 1.11% 27
2024
Q2
$8.96M Sell
151,687
-2,546
-2% -$159K 1.14% 27
2024
Q1
$12.3M Sell
154,233
-6,405
-4% -$489K 1.56% 20
2023
Q4
$12.7M Sell
160,638
-1,170
-0.7% -$83.3K 1.75% 19
2023
Q3
$11.3M Sell
161,808
-1,620
-1% -$115K 1.7% 19
2023
Q2
$11.3M Buy
163,428
+375
+0.2% +$26.7K 1.63% 20
2023
Q1
$12.1M Buy
163,053
+3,725
+2% +$312K 1.85% 17
2022
Q4
$14.8M Buy
159,328
+300
+0.2% +$28.9K 2.44% 10
2022
Q3
$15.2M Buy
159,028
+465
+0.3% +$46K 2.74% 10
2022
Q2
$14.7M Sell
158,563
-1,120
-0.7% -$109K 2.49% 11
2022
Q1
$16.2M Buy
159,683
+2,806
+2% +$295K 2.34% 13
2021
Q4
$16.2M Sell
156,877
-8,091
-5% -$748K 2.27% 13
2021
Q3
$14M Sell
164,968
-550
-0.3% -$46.1K 2.1% 13
2021
Q2
$13.8M Sell
165,518
-15
-0% -$1.23K 2.07% 14
2021
Q1
$12.5M Sell
165,533
-260
-0.2% -$18.9K 2% 15
2020
Q4
$11.3M Buy
165,793
+3,763
+2% +$245K 1.95% 16
2020
Q3
$9.46M Sell
162,030
-438
-0.3% -$27.3K 1.84% 17
2020
Q2
$10.6M Sell
162,468
-10
-0% -$630 2.19% 14
2020
Q1
$9.64M Sell
162,478
-2,000
-1% -$134K 2.29% 8
2019
Q4
$12.2M Sell
164,478
-2,842
-2% -$200K 2.44% 10
2019
Q3
$10.6M Buy
167,320
+2,529
+2% +$150K 2.26% 11
2019
Q2
$8.98M Buy
164,791
+1,177
+0.7% +$63.4K 1.93% 16
2019
Q1
$8.82M Sell
163,614
-3,650
-2% -$225K 1.97% 16
2018
Q4
$11M Sell
167,264
-307
-0.2% -$22.9K 2.7% 9
2018
Q3
$13.2M Sell
167,571
-8,091
-5% -$578K 2.9% 7
2018
Q2
$11.3M Buy
175,662
+1,110
+0.6% +$73.2K 2.61% 8
2018
Q1
$10.9M Sell
174,552
-425
-0.2% -$30.5K 2.56% 8
2017
Q4
$12.7M Buy
174,977
+1,844
+1% +$134K 2.86% 7
2017
Q3
$14.1M Buy
173,133
+2,973
+2% +$235K 3.32% 7
2017
Q2
$13.7M Buy
170,160
+3,284
+2% +$259K 3.26% 7
2017
Q1
$13.1M Buy
166,876
+10,530
+7% +$841K 3.11% 8
2016
Q4
$12.3M Buy
156,346
+15,724
+11% +$1.27M 3.03% 8
2016
Q3
$12.5M Buy
140,622
+535
+0.4% +$50.5K 3.11% 8
2016
Q2
$13.4M Sell
140,087
-915
-0.6% -$91.2K 3.37% 8
2016
Q1
$14.6M Sell
141,002
-970
-0.7% -$94.3K 3.76% 7
2015
Q4
$13.9M Sell
141,972
-1,351
-0.9% -$132K 3.63% 8
2015
Q3
$13.8M Sell
143,323
-690
-0.5% -$72.5K 3.86% 7
2015
Q2
$15.1M Sell
144,013
-1,262
-0.9% -$129K 3.99% 7
2015
Q1
$15M Sell
145,275
-1,030
-0.7% -$104K 3.98% 7
2014
Q4
$14.1M Sell
146,305
-1,425
-1% -$126K 3.89% 7
2014
Q3
$11.8M Sell
147,730
-675
-0.5% -$53.2K 3.4% 8
2014
Q2
$11.2M Sell
148,405
-425
-0.3% -$32.1K 3.31% 8
2014
Q1
$11.1M Sell
148,830
-1,175
-0.8% -$83K 3.35% 8
2013
Q4
$10.7M Buy
150,005
+700
+0.5% +$45K 3.28% 8
2013
Q3
$8.47M Sell
149,305
-4,250
-3% -$253K 2.81% 10
2013
Q2
$8.78M Buy
+153,555
New +$8.9M 2.95% 8

Other funds holding CVS

Parthenon LLC's CVS Position: Q2 2026 in Review

Parthenon LLC reduced its CVS Health (CVS) stake by 1.1% in Q2 2026, selling an estimated $107K and leaving 112,171 shares worth $11.6M. The position accounts for 1.21% of the portfolio, ranked #25.

Parthenon LLC first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.2M in Q4 2021. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Parthenon LLC held 112,171 shares of CVS Health worth $11.6M as of Q2 2026.
  • Parthenon LLC sold 1,200 CVS Health shares in Q2 2026, an estimated $107K.
  • CVS Health made up 1.21% of Parthenon LLC's portfolio in Q2 2026, its #25 holding.
  • Parthenon LLC first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Parthenon LLC's CVS Health position peaked at $16.2M in Q4 2021.
  • 937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Parthenon LLC's 13F filing for Q2 2026, filed 23 Jul 2026.